This Amendment No. 1 (the Amendment) is being filed jointly on behalf of H&F Corporate
Investors VIII, Ltd. (H&F VIII), Hellman & Friedman Investors VIII, L.P. (H&F Investors VIII), Hellman & Friedman Capital Partners VIII, L.P. (HFCP VIII),
Hellman & Friedman Capital Partners VIII (Parallel), L.P. (HFCP VIII Parallel), HFCP VIII (Parallel-A), L.P. (HFCP VIII
Parallel-A), H&F Executives VIII, L.P. (H&F VIII Executives), H&F Associates VIII, L.P. (H&F VIII Associates, and together with HFCP VIII, HFCP
VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the H&F Partnerships), H&F Polaris Partners, L.P. (Polaris Partners, and together with the H&F
Partnerships, the H&F Investors) and H&F Polaris Partners GP, LLC (Polaris Partners GP, and together with H&F VIII, H&F Investors VIII, and the H&F Investors, the Reporting
Persons) and amends the statement on Schedule 13D originally filed by the Reporting Persons on October 13, 2020 (the Original Schedule 13D, and as amended, the Schedule 13D) relating to the
Class A common stock, par value $0.0001 per share (the Common Stock) of MultiPlan Corporation (the Issuer).
The Items below amend the information disclosed under the corresponding Items of the Schedule 13D as described below. Except as specifically provided herein,
this Amendment does not modify any of the information previously reported in the Schedule 13D. Capitalized terms used but not defined herein shall have the meanings attributed to them in the Schedule 13D.
Item 4. Purpose of Transaction
Item 4 of the
Schedule 13D is hereby amended and supplemented as follows:
The closing price of the Common Stock on November 13, 2020, the most recently completed
trading day as of the date hereof, was $6.69 per share. The Reporting Persons believe that at such price the Common Stock is undervalued, and therefore currently intend to acquire additional shares of Common Stock of the Issuer through open market
purchases. Accordingly, the Reporting Persons have determined to promptly file with the Federal Trade Commission a Notification pursuant to the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the HSR Act), and
request early termination of the applicable waiting period to provide the Reporting Persons flexibility to make such additional purchases of Common Stock. Any determination to acquire additional Common Stock will be subject to market conditions and
all other relevant factors, and are dependent upon satisfaction of the requirements of the HSR Act.
In addition to the above, each Reporting Person,
consistent with its investment purpose and with the Investor Rights Agreement (as defined in Item 6 of this Schedule 13D), at any time and from time to time may directly or indirectly acquire additional shares of Common Stock or its associated
rights or securities exercisable for or convertible into Common Stock or dispose of any or all of its shares of Common Stock or its associated rights or securities exercisable for or convertible into Common Stock (including, without limitation,
distributing some or all of such securities to such Reporting Persons members, partners, stockholders or beneficiaries, as applicable) depending upon an ongoing evaluation of its investment in such securities, applicable legal and/or
contractual restrictions, prevailing market conditions, other investment opportunities, liquidity requirements of such Reporting Person and/or other investment considerations.
Other than as described above, each of the Reporting Persons reports that neither it nor, to its knowledge, any of the other persons named in Item 2 of this
Schedule 13D, currently has any plan or proposal which relates to, or may result in, any of the matters listed in Items 4(a)-(j) of Schedule 13D, although the Reporting Persons may, at any time and from time to time, review or reconsider their
position and/or change their purpose and/or formulate plans or proposals with respect thereto.
11